The most useful thing I can tell most patients about their genetics is that the genetics are not the story. The epigenome is.
Your DNA sequence is fixed at conception. What changes minute by minute, year by year, is which genes get switched on and which sit quiet. That switching happens through chemical marks on the DNA and on the proteins that package it. The marks are called epigenetic, and the field that studies them is epigenetics.
The marks are not inherited in the same way DNA is. They respond to what you eat, how you sleep, what you breathe, and how much you stress. That is the practical point. The epigenome is the modifiable layer between your DNA and your biology.
What is actually being measured
The most studied epigenetic mark is DNA methylation. A methyl group, a single carbon and three hydrogens, gets added to a specific stretch of DNA. The mark does not change the sequence underneath. It changes whether the sequence gets read.
When a gene that should be active gets methylated, it goes quiet. When a gene that should be quiet loses its methylation, it can become inappropriately active. Cancer biology, autoimmunity, neurodegeneration, and a meaningful slice of cardiovascular risk all have an epigenetic layer.
Methylation runs on a cycle that requires folate, B12, B6, choline, and methionine as inputs. When those inputs are short, the cycle slows. When the cycle slows, every downstream system relying on it slows with it.
Why I read it
Most clinicians do not look at the methylation cycle directly. They look at the downstream consequences and treat those. That works some of the time. It misses the upstream problem most of the time.
In my practice the question I am answering with a methylation panel is whether your cycle is bottlenecked, and if so, where. The bottleneck tells me which intervention will actually move the system instead of treating symptoms.
The panel reads:
- Homocysteine as the basic measure of cycle throughput
- The SAM/SAH ratio as the methylation potential of the cell
- The folate metabolites to see which step in the folate pathway is stalled
- The cystathionine handoff to read the trans-sulfuration arm
A patient with a slow methylation cycle, elevated homocysteine, a low SAM/SAH ratio, and a folate metabolite pattern suggesting MTHFR contribution has a clear intervention path. Active folate, methylated B12, B6, and lifestyle changes that lower demand on the cycle. Six to eight weeks later the panel reads different and the patient feels different.
What you can do without a panel
The methylation cycle responds to inputs whether or not you have measured it.
The strongest single lever is methyl-donor foods. Leafy greens, eggs, liver, and beets carry folate, choline, and B12 in their bioactive forms. Daily, not occasional.
The next lever is sleep on a rhythm. Methylation patterns reorganize overnight. Consistent sleep and wake times move the dial more than any supplement.
The third is load reduction. Alcohol, mercury exposure, BPA, and chronic stress all consume methyl groups. Drop the obvious sources first.
Zone-2 aerobic work and resistance training both raise methylation capacity. Two to four hours of zone-2 per week is the threshold.
How this connects to the rest of your biology
Epigenetics is one of the seven pillars I read in my practice. It does not stand alone. The methylation cycle interacts with your gut (the microbiome produces and consumes B vitamins), your mitochondria (oxidative stress consumes methyl donors), and your exposome (every toxin you clear costs methyl groups).
If you are doing the lifestyle work and not feeling the gains you would expect, the bottleneck is often here. If that describes you, the path in is the Precision Call. I will tell you what I see and whether a methylation panel is the right next read.
